208 related articles for article (PubMed ID: 1398282)
21. [Second cessation of therapy in children with acute lymphoblastic leukemia].
Rokicka-Milewska R; Derulska D; Jackowska T; Armata J; Balwierz W; Bogusławska-Jaworska J; Chybicka A; Cyklis R; Duczmal B; Jakowicka M
Acta Haematol Pol; 1992; 23(1):43-7. PubMed ID: 1615750
[TBL] [Abstract][Full Text] [Related]
22. Treatment of high-risk acute lymphoblastic leukemia with protocols PETHEMA LAL 7/78 and LAL 17/84.
Ortega JJ; Javier G; Olivé T
An Esp Pediatr; 1988 Oct; 29 Suppl 34():72-83. PubMed ID: 3214043
[No Abstract] [Full Text] [Related]
23. Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). German Adult ALL Study Group.
Hoelzer D; Thiel E; Ludwig WD; Löffler H; Büchner T; Freund M; Heil G; Hiddemann W; Maschmeyer G; Völkers B
Leukemia; 1993 Aug; 7 Suppl 2():S130-4. PubMed ID: 8361217
[No Abstract] [Full Text] [Related]
24. [Recurrences after completion of the treatment of acute lymphoblastic leukemia in children].
Ochocka M; Matysiak M; Newecka-Samól T; Kulus M; Armata J; Balwierz W; Bogusławska-Jaworska J; Chybicka A; Jackowska T; Jakowicka M
Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):350-3. PubMed ID: 1437752
[TBL] [Abstract][Full Text] [Related]
25. Influence of methylene tetrahydrofolate reductase polymorphisms and coadministration of antimetabolites on toxicity after high dose methotrexate.
van Kooten Niekerk PB; Schmiegelow K; Schroeder H
Eur J Haematol; 2008 Nov; 81(5):391-8. PubMed ID: 18691257
[TBL] [Abstract][Full Text] [Related]
26. B-lineage acute lymphoblastic leukemia of childhood. An institutional experience.
Rivera-Luna R; Cardenas-Cardos R; Leal-Leal C; Navarro-Alegría I; Meza-Coria C; Gómez-Martínez R; Vega-Vega L
Arch Med Res; 1997; 28(2):233-9. PubMed ID: 9204615
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.
Ribera JM; Oriol A; Sanz MA; Tormo M; Fernández-Abellán P; del Potro E; Abella E; Bueno J; Parody R; Bastida P; Grande C; Heras I; Bethencourt C; Feliu E; Ortega JJ
J Clin Oncol; 2008 Apr; 26(11):1843-9. PubMed ID: 18398150
[TBL] [Abstract][Full Text] [Related]
28. Clotting abnormalities in children during maintenance chemotherapy for acute lymphoblastic leukemia.
Aricò M; Gamba G; Raiteri E; Montani N; De Amici M; Burgio GR
Haematologica; 1991; 76(6):472-4. PubMed ID: 1820983
[TBL] [Abstract][Full Text] [Related]
29. Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.
Schaison G; Sommelet D; Bancillon A; Perel Y; Leblanc T; Bergeron C; Lejars O; Baruchel A; Lepage E; Leverger G
Leukemia; 1992; 6 Suppl 2():148-52. PubMed ID: 1578919
[No Abstract] [Full Text] [Related]
30. Childhood acute lymphoblastic leukemia (ALL): sister chromatid exchange (SCE) frequency and lymphocyte subpopulations during therapy.
Mertens R; Rubbert F; Büssing A
Leukemia; 1995 Mar; 9(3):501-5. PubMed ID: 7885047
[TBL] [Abstract][Full Text] [Related]
31. Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.
Tantawy AA; El-Bostany EA; Adly AA; Abou El Asrar M; El-Ghouroury EA; Abdulghaffar EE
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):28-34. PubMed ID: 19923983
[TBL] [Abstract][Full Text] [Related]
32. Inherited prothrombotic risk factors in Turkish children with acute lymphoblastic leukemia: significance of concomitant genetic mutation.
Torun YA; Patiroglu T; Ozdemir MA; Ozkul Y; Ekici A; Karakukcu M
Clin Appl Thromb Hemost; 2012; 18(2):218-21. PubMed ID: 21873357
[TBL] [Abstract][Full Text] [Related]
33. Increased factor VIII activity and dural sinus thrombosis.
Celkan T; Ozkan A; Apak H; Kuruoglu S; Yuksel L; Yildiz I
Med Pediatr Oncol; 2002 Jul; 39(1):71-2. PubMed ID: 12116089
[No Abstract] [Full Text] [Related]
34. GIMEMA ALL 0288: a multicentric study on adult acute lymphoblastic leukemia. Preliminary results.
Mandelli F; Annino L; Vegna ML; Camera A; Ciolli S; Deplano W; Fabiano F; Ferrara F; Ladogana S; Muti G
Leukemia; 1992; 6 Suppl 2():182-5. PubMed ID: 1578928
[No Abstract] [Full Text] [Related]
35. Experience with high dose methotrexate therapy in childhood acute lymphoblastic leukemia in a tertiary care cancer centre of a developing country.
Kapoor G; Sinha R; Abedin S
Pediatr Blood Cancer; 2012 Sep; 59(3):448-53. PubMed ID: 22271707
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of IKZF1 deletions in association with vincristine-dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial ALL-BFM 95.
Hinze L; Möricke A; Zimmermann M; Junk S; Cario G; Dagdan E; Kratz CP; Conter V; Schrappe M; Stanulla M
Leukemia; 2017 Aug; 31(8):1840-1842. PubMed ID: 28529312
[No Abstract] [Full Text] [Related]
37. [Induction and interval treatment of leukemias in children and juveniles].
Oehme J; Meyer-Beeck D
Dtsch Med Wochenschr; 1969 Sep; 94(39):1993-6. PubMed ID: 5352272
[No Abstract] [Full Text] [Related]
38. Extended duration of prehydration does not prevent nephrotoxicity or delayed drug elimination in high-dose methotrexate infusions: a prospectively randomized cross-over study.
Mikkelsen TS; Mamoudou AD; Tuckuviene R; Wehner PS; Schroeder H
Pediatr Blood Cancer; 2014 Feb; 61(2):297-301. PubMed ID: 24039194
[TBL] [Abstract][Full Text] [Related]
39. Retrospective study on elimination delay of methotrexate in high-dose therapy of childhood acute lymphoblastic leukemia in China.
Xu W; Tang Y; Song H; Shi S; Yang S
J Pediatr Hematol Oncol; 2007 Oct; 29(10):688-93. PubMed ID: 17921849
[TBL] [Abstract][Full Text] [Related]
40. [Diagnostic significance of reticulocyte analysis by flow cytometry, in children with acute lymphoblastic leukaemia (ALL) on chemotherapy].
Ratomski K; Wysocka J; Leszczyńska E; Krawczyk-Rybak M; Zak J
Med Wieku Rozwoj; 2004; 8(2 Pt 1):259-65. PubMed ID: 15738601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
